Developmental or Procedural Vena Cava Interruption and Venous Thromboembolism: A Review

Author:

Bikdeli Behnood1234,Sadeghipour Parham56,Lou Junyang1,Bejjani Antoine12,Khairani Candrika D.12,Rashedi Sina5,Lookstein Robert7,Lansky Alexandra8,Vedantham Suresh9,Sobieszczyk Piotr1,Mena-Hurtado Carlos8,Aghayev Ayaz10,Henke Peter11,Mehdipoor Ghazaleh412,Tufano Antonella13,Chatterjee Saurav14,Middeldorp Saskia15,Wasan Suman16,Bashir Riyaz17,Lang Irene M.18,Shishehbor Mehdi H.19,Gerhard-Herman Marie1,Giri Jay20,Menard Matthew T.21,Parikh Sahil A.422,Mazzolai Lucia23,Moores Lisa24,Monreal Manuel25,Jimenez David262728,Goldhaber Samuel Z.12,Krumholz Harlan M.3829,Piazza Gregory12

Affiliation:

1. Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts

2. Thrombosis Research Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts

3. YNHH/Yale Center for Outcomes Research and Evaluation (CORE), New Haven, Connecticut

4. Cardiovascular Research Foundation (CRF), New York, New York

5. Rajaie Cardiovascular, Medical, and Research Center, Iran University of Medical Sciences, Tehran, Iran

6. Clinical Trial Center, Rajaie Cardiovascular, Medical, and Research Center, Iran University of Medical Sciences, Tehran, Iran

7. Division of Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, New York

8. Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut

9. Mallinckrodt Institute of Radiology, Washington University in St. Louis, St. Louis, Missouri

10. Cardiovascular Imaging Program, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts

11. Section of Vascular Surgery, Department of Surgery, University of Michigan, Ann Arbor, Michigan

12. Center for Evidence-based Imaging, Brigham and Women's Hospital, Boston, Massachusetts

13. Department of Clinical Medicine and Surgery, Federico II University Hospital, Naples, Italy

14. Division of Cardiology, Department of Medicine, Zucker School of Medicine, New York, New York

15. Department of Internal Medicine, Radboud Institute of Health Sciences (RIHS), Radboud University Medical Center, Nijmegen, The Netherlands

16. University of North Carolina, Chapel Hill, North Carolina

17. Departement of Cardiovascular Diseases, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania

18. Department of Internal Medicine II, Cardiology and Center of Cardiovascular Medicine, Medical University of Vienna, Vienna, Austria

19. University Hospitals Heath System, Harrington Heart and Vascular Institute, Cleveland, Ohio

20. Penn Cardiovascular Outcomes, Quality, and Evaluative Research Center, Cardiovascular Division, University of Pennsylvania, Philadelphia, Pennsylvania

21. Division of Vascular and Endovascular Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts

22. Division of Cardiology, New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York

23. Division of Angiology, Heart and Vessel Department, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland

24. Department of Medicine, Uniformed Services University of Health Sciences, Bethesda, Maryland

25. Universidad Católica San Antonio de Murcia, Spain

26. Respiratory Department, Hospital Ramón y Cajal (IRYCIS), Madrid, Spain

27. Medicine Department, Universidad de Alcalá (IRYCIS), Madrid, Spain

28. CIBER Enfermedades Respiratorias (CIBERES), Madrid, Spain

29. Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut

Abstract

AbstractThe inferior vena cava (IVC) and superior vena cava are the main conduits of the systemic venous circulation into the right atrium. Developmental or procedural interruptions of vena cava might predispose to stasis and deep vein thrombosis (DVT) distal to the anomaly and may impact the subsequent rate of pulmonary embolism (PE). This study aimed to review the various etiologies of developmental or procedural vena cava interruption and their impact on venous thromboembolism. A systematic search was performed in PubMed according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines per each clinical question. For management questions with no high-quality evidence and no mutual agreements between authors, Delphi methods were used. IVC agenesis is the most common form of congenital vena cava interruption, is associated with an increased risk of DVT, and should be suspected in young patients with unexpected extensive bilateral DVT. Surgical techniques for vena cava interruption (ligation, clipping, and plication) to prevent PE have been largely abandoned due to short-term procedural risks and long-term complications, although survivors of prior procedures are occasionally encountered. Vena cava filters are now the most commonly used method of procedural interruption, frequently placed in the infrarenal IVC. The most agreed-upon indication for vena cava filters is for patients with acute venous thromboembolism and coexisting contraindications to anticoagulation. Familiarity with different forms of vena cava interruption and their local and systemic adverse effects is important to minimize complications and thrombotic events.

Publisher

Georg Thieme Verlag KG

Subject

Cardiology and Cardiovascular Medicine,Hematology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3